By Catherine Eckford (European Pharmaceutical Review)2023-11-10T16:23:53
Future regulatory authorisation is expected in Europe, following the US Food and Drug Administration (FDA)’s accelerated approval of IXCHIQ®.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-30T14:00:00Z 2026-06-30T15:00:00Z
Sponsored by BioRad
2026-04-14T12:32:00Z
Sponsored by Thermo Fisher Scientific
2026-04-14T12:29:00Z
Sponsored by JRS Pharma, In association with Vetter Pharma
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-06-11T13:00:00
Sponsored by Rapid Micro Biosystems
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
2025-06-03T13:35:00
Sponsored by bioMérieux, By European Pharmaceutical Review
2025-12-03T07:58:01
Sponsored by MBV AG
2025-09-19T15:52:00
Sponsored by Sanner, By Uwe Raupbach (Sanner)
Site powered by Webvision Cloud